Research from Atrium Research, Atrium Research Corporation

Atrium Research

Atrium Research provides institutional quality issuer paid research on public equities in North America. Our investment philosophy takes a 3-5 year view on equities currently being overlooked by the market. Our research process emphasizes understanding the key performance metrics for each specific company, trustworthy management teams, unit economics, and an in-depth valuation analysis.

Our research product includes in-depth initiation reports, research notes, thematic research pieces, and company fact sheets.

Research from Atrium Research

Atrium Research Corporation

Atrium Research provides institutional quality issuer paid research on public equities in North America. Our investment philosophy takes a 3-5 year view on equities currently being overlooked by the market. Our research process emphasizes understanding the key performance metrics for each specific company, trustworthy management teams, unit economics, and an in-depth valuation analysis. 

Our research product includes in-depth initiation reports, research notes, thematic research pieces, and company fact sheets.

Equity Bottom-Up

<ul>
<li>ARG reported Q2/26 financials, with revenue of $77.4M (+52% YoY) versus our $73.2M estimate, driven by a realized copper price of $6.16/lb.</li>
<li>EBITDA was $38.4M (50% margin), ahead of our $35.2M estimate and up 115% from $17.8M in Q2/25.</li>
<li>EBITDA for H1 was $71.2M, nearly hitting the Company’s 2026 guidance of $74.5M.</li>
</ul>


ARG reported Q2/26 financials, with revenue of $77.4M (+52% YoY) versus our $73.2M estimate, driven by a realized copper price of $6.16/lb.
EBITDA was $38.4M (50% margin), ahead of our $35.2M estimate and up 115% from $17.8M in Q2/25.
EBITDA for H1 was $71.2M, nearly hitting the Company’s 2026 guidance of $74.5M.


ARG: Strong Q2 Financials; 96% of 2026 EBITDA Guidance Achieved

Amerigo Resources

ARG: Strong Q2 Financials; 96% of 2026 EBITDA Guidance Achieved